4,0
14. Feb. 2024
Aktueller Mitarbeiter, mehr als 10 Jahre
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
They have good benefits and in general treat their employees well
Kontras
too much red tape and non value added work. Some poor senior execs have lead to a loss of confidence and direction of the company - and Roche is killing the stock price. Difficult to get promoted if you're not part of the 'in crowd' in your area.